Details of the Drug Formulaction

General Information of Drug Formulation (ID: F21845)

• Formulation Name: Valproic acid 125 mg capsule
• Company: Cadila Healthcare

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Valproate	(DMCFE9I)	Epilepsy	8A60-8A68	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
FD&C blue no. 1	(E00263)	19700	Colorant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Triethyl citrate	(E00128)	6506	Plasticizing agent; Solvent